Microbiology News: clinical, Nov 2021

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

Microbiology News: clinical, Nov 2021

Assay Development Clinical Cosmetic/Personal Care Food & Beverage Laboratory Equipment Microbiome Other Pharmaceutical Veterinary Water

Special Focus on Molecular Testing for SARS-CoV-2 (COVID-19) Variants Including Omicron

30 Nov 2021 | WaterClinical

Recombinant Omicron Variants are Available

This special focus on 'Molecular Testing of SARS-CoV-2 Variants' includes featured products from suppliers around the world, who can provide you with reagents, equipment, and test kits allowing you to optimize your COVID-19 testing workflow. more...

The Marketing Solution for Global Microbiology Brands - Video

29 Nov 2021 | Food & BeverageWaterClinicalOtherPharmaceuticalMicrobiome

Best channel for marketing microbiology kits and products

Watch this short explainer video to find out how rapidmicrobiology is going to be a great fit for your marketing campaigns in 2025. Get sales leads, develop and position brands, gain event attendees and establish your thought leadership expertise. more...

Microbiologics Has Named Greg Swanson as Vice President of Sales and Marketing

24 Nov 2021 | Food & BeverageClinicalPharmaceutical

Swanson will lead the global sales, business development and marketing functions to drive future growth and profitability. He has over 25 years of sales and marketing leadership experience in the medical device industry. more...

Diagnosis of Invasive Fungal Disease Within an Hour

16 Nov 2021 | Clinical

The IMMY range of lateral flow assays, available from Alpha Laboratories, provide simple-to-use, rapid diagnostic assays to aid fungal disease detection and support early diagnosis and patient management. more...

FDA-Cleared MTS™ (MIC Test Strip) Piperacillin-tazobactam (TZP)

15 Nov 2021 | Clinical

Liofilchem has received clearance from the FDA to market the Piperacillin-tazobactam 0.016/4-256/4 MTS™ (MIC Test Strip) in the United States. more...

QC Microorganisms Simplifying Microbiology Control and Eliminating Prep Work

15 Nov 2021 | Food & BeverageClinicalPharmaceuticalVeterinaryCosmetic/Personal Care

Instant Inoculator™ transfers isolated colonies to solid media, requiring no prep, no rehydration, and no liquid handling, positing itself as the easiest and simplest way to work with reference microorganisms. more...

Bulk Gold Nanoparticle Production for Minimized Manufacturing Risk

10 Nov 2021 | Clinical

As one of the world’s largest gold nanoparticle manufacturers, we can leverage our scaled production to produce the highest quality and lowest priced gold colloid for rapid diagnostic tests. No commercial use license is required for our gold colloid products – simply purchase and use. more...

Protecting Women’s Health – HPV Testing Assists in Eliminating Cervical Cancer

08 Nov 2021 | Clinical

Bioperfectus Human Papillomavirus Genotyping Real Time PCR Kit

Bioperfectus Human Papillomavirus Real-Time PCR Kit is able to detect 96 samples in 100 minutes with the ability to respectively report HPV-16 and HPV-18 as primary evidence for cervical cancer screening. more...

A New Lateral Flow Reader for Fluorescence-Labeled Lateral Flow Tests

05 Nov 2021 | Food & BeverageClinicalOther

IUL SA presents iPeak® Europium a new off-the-shelf lateral flow reader designed to scan fluorescence-labeled lateral flow tests. more...

Want to Improve the Sensitivity of Your Lateral Flow Assay? We Have a Solution

04 Nov 2021 | Clinical

Our BioReady Gold Nanoshell particles can deliver 6 to 20 times greater sensitivity in lateral flow assays compared to 40 nm diameter gold colloid. more...

Biofortuna Double Their Manufacturing Capacity to the IVD and POC Testing Sectors

04 Nov 2021 | Clinical

Specialist contract development and manufacturing IVD and POC

Biofortuna the specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has relocated to new purpose built manufacturing facilities in Deeside,UK more...

US FDA 510(K) Clearance for MRSA Analysis Module

01 Nov 2021 | Clinical

The APAS Independence with MRSA Analysis Module has been cleared as a Class II medical device by the FDA. The APAS Independence automates the screening, sorting, and interpretation of culture plates and remains the first of its kind to auto-verify negative culture plates in the United States. more...